Tuesday, May 19, 2026

Google’s New Distributed Cloud: AI Power Where You Least Expect It

Google Cloud announced that it has launched Google Distributed Cloud, which provides Google's cloud and AI technology in a ...

Do You Think This Customer’s Actions Were Justified?

Criticism is pouring in against a customer...

Supreme Court Confirms Two Year Prison Sentence For Representative Ha Yeon Ho Following Years Of Contact With North Korean Agents

The South Korean Supreme Court upheld a two-year prison sentence for Ha Yeon-ho for communicating with North Korean operatives.

Tag: CGBIO

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

CGBio's DCLASSY PDRN skin booster gains IDE approval for clinical trials targeting eye wrinkles, enhancing patient satisfaction and market competitiveness.

How ExcelOs Inject Revolutionizes Bone Grafting: Insights from the Latest GBR Seminar

CGBIO hosted a hands-on seminar for dental professionals, focusing on practical skills in maxillary sinus lifts and bone grafting techniques.

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

What Makes DOOTH the Game-Changer in Absorbable Sutures? Discover Its Unique Advantages!

CGBio is expanding its aesthetic business by exporting the absorbable suture DOOTH to Japan, aiming for global recognition and regulatory approvals.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

IMCAS 2026: Discover How Sijibio Secured Over 70.4 Million USD in Global Contracts

CGBIO showcased its collagen stimulator at IMCAS 2026, securing contracts worth 101.5 billion KRW to strengthen its global market position.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.